Comparison of continuous infusion versus bolus injection of factor concentrates for blood management after total knee arthroplasty in patients with hemophilia

[1]  E. Santagostino,et al.  Continuous infusion of recombinant factor VIII formulated with sucrose in surgery: Non‐interventional, observational study in patients with severe haemophilia A , 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

[2]  R. Schuh,et al.  Outcome of total knee arthroplasty in hemophilic arthropathy. , 2014, The Journal of arthroplasty.

[3]  P. Pennekamp,et al.  Knieendoprothetik für Patienten mit Hämophilie , 2014 .

[4]  G. Tjønnfjord,et al.  Haemophilic arthropathy: long-term outcomes in 107 primary total knee arthroplasties. , 2014, The Knee.

[5]  T. Wallny,et al.  Elective total knee arthroplasty in haemophilic patients. Proposal for a clinical pathway. , 2014, Hamostaseologie.

[6]  E. Rodríguez‐Merchán.  Special features of total knee replacement in hemophilia , 2013, Expert review of hematology.

[7]  G. Auerswald,et al.  No inhibitor development after continuous infusion of factor concentrates in subjects with bleeding disorders undergoing surgery: a prospective study , 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

[8]  A. Lienhart,et al.  Seventy‐two total knee arthroplasties performed in patients with haemophilia using continuous infusion , 2013, Vox sanguinis.

[9]  N. Goddard,et al.  Perioperative clotting factor replacement and infection in total knee arthroplasty , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

[10]  F. Leebeek,et al.  Inhibitor incidence after intensive FVIII replacement for surgery in mild and moderate haemophilia A: a prospective national study in the Netherlands , 2012, British journal of haematology.

[11]  J. Sibilia,et al.  Total knee arthroplasty in severe haemophilic patients under continuous infusion of clotting factors , 2012, Knee Surgery, Sports Traumatology, Arthroscopy.

[12]  H. Takedani.  Continuous infusion during total joint arthroplasty in Japanese haemophilia A patients: comparison study among two recombinants and one plasma‐derived factor VIII , 2010, Haemophilia.

[13]  N. Goddard,et al.  Total knee replacement in patients with end-stage haemophilic arthropathy: 25-year results. , 2010, The Journal of bone and joint surgery. British volume.

[14]  M. Yoo,et al.  The outcome of cementless total hip arthroplasty in haemophilic hip arthropathy , 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

[15]  H. Stass,et al.  Stability, efficacy, and safety of continuously infused sucrose‐formulated recombinant factor VIII (rFVIII‐FS) during surgery in patients with severe haemophilia , 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

[16]  J. Astermark,et al.  Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conference , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

[17]  A. Batorova,et al.  Continuous infusion of coagulation factors: current opinion , 2006, Current opinion in hematology.

[18]  J. Oldenburg,et al.  Inhibitor Development in Patients with Hemophilia A after Continuous Infusion of FVIII Concentrates , 2005, Annals of the New York Academy of Sciences.

[19]  J. Luck,et al.  Long-term results of primary total knee replacement in patients with hemophilia. , 2005, The Journal of bone and joint surgery. American volume.

[20]  D. Dingli,et al.  Continuous factor VIII infusion therapy in patients with haemophilia A undergoing surgical procedures with plasma‐derived or recombinant factor VIII concentrates , 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

[21]  R. Laskin,et al.  Infection in Total Knee Replacement: A Retrospective Review of 6489 Total Knee Replacements , 2001, Clinical orthopaedics and related research.

[22]  E. Berntorp,et al.  Pharmacokinetics of Coagulation Factors , 2001, Clinical pharmacokinetics.

[23]  A. Batorova,et al.  Intermittent injections vs. continuous infusion of Factor VIII in haemophilia patients undergoing major surgery , 2000, British journal of haematology.

[24]  C. C. Patrick,et al.  Stability and sterility of a recombinant factor viii concentrate prepared for continuous infusion administration , 1999, American journal of hematology.

[25]  S. Schulman,et al.  Continuous infusion of factor concentrates: review of use in hemophilia A and demonstration of safety and efficacy in hemophilia B. , 1995, Acta haematologica.

[26]  S. Schulman,et al.  Monoclonal purified F VIII for continuous infusion: stability, microbiological safety and clinical experience. , 1994, Thrombosis and haemostasis.

[27]  S. Schulman,et al.  Stability of factor VIII concentrates after reconstitution , 1994, American journal of hematology.

[28]  S. Schulman,et al.  Adjusted dose continuous infusion of factor VIII in patients with haemophilia A , 1992, British journal of haematology.

[29]  K. Heiple,et al.  Total knee arthroplasty for the treatment of chronic hemophilic arthropathy. , 1989, Clinical orthopaedics and related research.

[30]  I. Novàkovà,et al.  Total knee replacement in haemophilic arthropathy. , 1988, The Journal of bone and joint surgery. British volume.

[31]  N. Rana,et al.  Long‐term follow‐up of prosthetic joint replacement in hemophilia , 1986, American journal of hematology.

[32]  C. Mcmillan,et al.  Continuous Intravenous Infusion of Factor VIII in Classic Haemophilia , 1970, British journal of haematology.